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Background: Bone marrow mesenchymal stem cells (BM-MSCs) are capable of differentiating into endothelial cells
in vitro and acquire major characteristics of mature endothelial-like expression of vWF and CD31. SFAs and lipid
oxidation products have been linked with postprandial endothelial dysfunction. Consumption of SFAs impairs
arterial endothelial function, while a Mediterranean-type MUFA-diet has a beneficial effect on endothelial function
by producing a decrease in levels of vWF, TFPI and PAI-1. Stearoyl-CoA desaturase 1 (SCD1), which converts SFA
to MUFA, is involved in the cellular biosynthesis of MUFAs from SFA substrates. High expression of SCD1 is
corresponded with low rates of fatty acid oxidation, therefore it might reduce inflammatory responses and be
beneficial for the growth of induced endothelial cells. Overexpression of SCD1 in BM-MSCs might increase the
growth of induced endothelial cells. The goal of this research is to study the relationship between overexpression
of SCD1 and the expression of induced endothelial cells in BM-MSCs in vitro.
Methods: The gene SCD1 was integrated into a lentiviral vector, and then 293 T cells were transfected by the
connected product to produce a packaged virus. BM-MSCs were infected by the packaged virus. Cell culture and
endothelial induction were performed. Fluorescent quantitative PCR of CD31, vWF and VE-cad was performed after
1 week and 2 weeks to test the growth of induced endothelial cells.
Results: The mRNA amount of CD31, vWF and VE-cad of the SCD1 overexpressed group was statistically higher
than that of the empty vector (EV) group and that of the normal group after 1 week and 2 weeks, respectively
(p < 0.05). Immunocytochemical staining of CD31 or vWF was detected by visualizing red color.
Conclusions: This study suggested that overexpression of SCD1 in BM-MSCs could increase the expression of
induced endothelial cells in vitro.
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Stearoyl-CoA desaturase 1 (SCD1), known as a Δ9 desa-
turase, is an integral membrane protein anchored in the
endoplasmic reticulum [1]. SCD1 converts saturated fatty
acids (SFAs) to monounsaturated fatty acids (MUFAs),
which make up the primary storage of unsaturated fatty
acids in human adipose tissue [2].
An inverse relationship between endothelial function
and SFA has been shown in healthy adults [3]. Plasma* Correspondence: taojie123@sjtu.edu.cn
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unless otherwise stated.SFA, which partly reflects dietary fat quality, has an
important impact on endothelial function. Consumption
of SFAs reduces the anti-inflammatory properties of
HDL and impairs endothelial function [4]. In healthy ad-
olescents, impaired endothelial function is significantly
associated with high level of soluble ICAM-1, HOMA-IR
and SFA [5].
Mesenchymal stem cells (MSCs) are multipotent stem
cells that can be isolated from many human adult or fetal
tissues. MSCs were found to differentiate into cartilage,
bone, fat, muscle, and other connective tissues [6,7]. In
endothelial differentiation system, human bone marrow-
derived (CD105+, CD29+, CD34–) MSCs are capable ofThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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major characteristics of mature endothelial-like expression
of von Willebrand factor (vWF) and CD31 [8]. This will
make bone marrow mesenchymal stem cells (BM-MSCs)
attractive candidates for the development of autologous
tissue graft. Overexpression of SCD1 in BM-MSCs might
have advantages for the expression of induced endothelial
cells by reducing the the amount of SFAs in human bodies.
Up to now, there has been no report in the literature of
the relationship between the overexpression of SCD1 and
the expression of induced endothelial cells in BM-MSCs.
The goal of this research is to study the relationship
between the overexpression of SCD1 and the expression
of induced endothelial cells in BM-MSCs in vitro.
Results
Vector construction and virus packaging
GFP fluorescence imaging showed that the 293 T cells
were transfected by viral vector successfully after 48 h
(Figure 1a), and the packaged virus infected 293 T cells
successfully after 48 h (Figure 1b). The titer of viral vec-
tor was calculated according to the results of flow cy-
tometry (Figure 1d). The title calculation is as follows:Figure 1 GFP fluorescence and flow cytometry. (a) GFP fluorescence im
48 h. (b) GFP fluorescence imaging showed that the packaged virus infecte
BM-MSCs were infected by the packaged virus. (d) The results of flow cyto
was GFP positive. (e) The results of flow cytometry on BM-MSCs showed thtiter (293 T-transducing units/ml) = 100,000 (target 293 T
cells) × (% of GFP-positive cells/100)/volume of super-
natant (ml). The titer of this experiment is 5.17 × 108 TU/
ml. BM-MSCs were infected by the packaged virus suc-
cessfully (Figure 1c). The results of flow cytometry on
BM-MSCs (Figure 1e) showed that 87.2% of the total
cells were GFP positive.
Overexpression of SCD1
RT-PCR showed that the amount of SCD1 mRNA in the
SCD1 overexpressed group was 8.86 ± 0.94 and that the
amount of the empty vector (EV) group was 1.00 ± 0.09.
The expression of SCD1 mRNA of the SCD1 overexpressed
group is statistically higher than that of the EV group (p <
0.01) (Figure 2a). Enzyme activity measurement showed
that the activity of SCD1 in the SCD1 overexpressed group
was 35.87 ± 3.11 and that the activity of the empty vector
(EV) group was 23.75 ± 2.16. SCD1 activity of the SCD1
overexpressed group is statistically higher than that of the
EV group (p < 0.01) (Figure 2b). A western blot of SCD1
showed that the concentration of SCD1 in the SCD1 over-
expressed group was higher than that of the EV group
(Figure 3).aging showed that 293 T cells were transfected by viral vector after
d 293 T cells after 48 h. (c) GFP fluorescence imaging showed that
metry on 293 T cells showed that 51.7% of the total number of cells





























































Figure 2 Realtime PCR and activity results of SCD1. Realtime PCR and enzyme activity analysis results showed that the amount of SCD1
mRNA (a) and enzyme activity (b) of the SCD1 overexpressed group was higher than that of the EV group (p < 0.01).
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The results of fluorescent quantitative PCR (Table 1,
Figure 4) showed that the mRNA amount of CD31 of the
SCD1 overexpressed group was higher than that of the EV
group after 1 week and 2 weeks (p < 0.05), and was signifi-
cantly higher than that of the normal group after 1 week
and 2 weeks (p < 0.01). The mRNA amount of vWF of the
SCD1 overexpressed group was higher than that of the EV
group after 1 week and 2 weeks (p < 0.05) and that of the
normal group after 2 weeks (p < 0.05), and was signifi-
cantly higher than that of the normal group after 1 week
(p < 0.01). The mRNA amount of VE-cad of the SCD1
overexpressed group was significantly higher than that of
the EV group and that of the normal group after 1 week
and 2 weeks (p < 0.01). Meanwhile, vWF and CD31
staining could be detected and the positive staining is
visualized by red color (Figure 5a, b, c for vWF and d, e, f
for CD31).
Discussion
SCD1 has been regarded as the switch between fatty acid
storage and consumption as well as in promoting or pre-
venting lipid-induced disorders [9,10]. SCD1 is involved in
the cellular biosynthesis of MUFAs from SFA substrates.
The substrates of SCD1 are mainly stearoyl-CoA (C18:0)Figure 3 Vector construction of SCD1 overexpression. (a) An electroph
of the PCR products of connected vector pCDH-SCD1. (c) Western blot of SCD
group is higher than that in the EV group.and palmitoyl-CoA (C16:0), which are desaturated to
oleoyl-CoA (C18:1) and palmitoleoyl-CoA (C16:1), re-
spectively. SCD1 prefers to convert stearate to oleate ra-
ther than palmitate to palmitoleate [11], both of which
make up the primary storage of unsaturated fatty acids in
human adipose tissue [2]. The major MUFAs generated by
SCD1 represent the main substrates for synthesis of
triglycerides, cholesterol esters and phospholipids. Con-
sistent with its role as a key player in metabolic control,
SCD1 activity is tightly regulated, being decreased by un-
saturated fatty acids (UFAs) and increased by SFAs [12].
MSCs were found to differentiate into cartilage, bone,
fat, muscle, and other connective tissues [6,7] depending
on the culture conditions, which include supplementa-
tion of lineage-specific inducing agents as well as hor-
mones and growth factors. Studies have demonstrated
that mesoderm-derived MSCs originate from precursors
with angiogenic potential, called mesenchymomagioblasts,
which are identified as MS-CFCs with the potential to dif-
ferentiate into both MSCs and endothelial cells [13]. In
endothelial differentiation system, human bone marrow-
derived (CD105+, CD29+, CD34–) MSCs are capable of
differentiating into endothelial cells in vitro and acquire
major characteristics of mature endothelial-like expression
of vWF and CD31 [8]. In addition, MSCs give rise tooresis map of the PCR products of SCD1. (b) An electrophoresis map
1 showed that the concentration of SCD1 in the SCD1 overexpressed











CD31 (1 week) 1.70 ± 0.18 (6) 1.39 ± 0.23 (6) 1.15 ± 0.02 (6) 0.013* <0.01**
CD31 (2 weeks) 6.78 ± 0.93 (6) 5.51 ± 1.05 (6) 4.37 ± 0.54 (6) 0.025* <0.01**
vWF (1 week) 3.21 ± 0.36 (6) 2.80 ± 033 (6) 1.87 ± 0.27 (6) 0.033* <0.01**
vWF (2 weeks) 6.25 ± 0.56 (6) 5.21 ± 0.57 (6) 5.80 ± 0.20 (6) 0.048* 0.047*
VE-cad (1 week) 4.11 ± 0.51 (6) 1.70 ± 0.07 (6) 1.49 ± 0.05 (6) <0.01** <0.01**
VE-cad (2 weeks) 5.36 ± 0.07 (6) 3.37 ± 0.19 (6) 3.24 ± 0.16 (6) <0.01** <0.01**
*p value < 0.05 expressed mRNA expression of CD31, vWF or VE-cad of the SCD1 overexpressed group was statistically higher than that of the EV group or that of
the normal group after 1 week and 2 weeks.
**p value < 0.01 expressed mRNA expression of CD31, vWF or VE-cad of the SCD1 overexpressed group was statistically significantly higher than that of the EV
group or that of the normal group after 1 week and 2 weeks.
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formation of the hematopoietic stem cell niche [14,15]
and vascular wall [16].
In this study, GFP fluorescence imaging showed that
BM-MSCs were infected by the packaged virus, and
RT-PCR results showed that the expression of SCD1
mRNA of the SCD1 overexpressed group is higher than
that of the EV group (p < 0.01). So overexpression of SCD1
in BM-MSCs was achieved successfully. Commonly used
markers of the endothelium include CD31 and vWF [17].
Vascular endothelial cadherin (VE-cad), a putative member
of the type II subfamily [18,19] is specifically expressed in
endothelial cells and is not found in any other cell type
[20,21]. In order to test the growth of induced endothelialFigure 4 Realtime PCR results of CD31, vWF and VE-cad. Realtime PCR
the SCD1 overexpressed group was higher than that of the EV group andcells, CD31, vWF and VE-cad in MSCs were assayed, and
the results of fluorescent quantitative PCR suggested that
the mRNA amount of CD31, vWF, VE-cad of the SCD1
overexpressed group was statistically higher than that of
the EV group and that of the normal group after 1 week
and 2 weeks (p < 0.05). This result indicated that over-
expression of SCD1 in BM-MSCs could increases the
expression of induced endothelial cells in vitro.
SFAs and lipid oxidation products have been linked
with postprandial endothelial dysfunction [4,22] and ath-
erosclerotic disease. Diets rich in SFAs [23] or oxidized
fatty acids [24] accelerate the formation of atherosclerotic
lesions in animals. High intake of SFAs has been associ-
ated with an increased incidence of coronary heart diseaseresults showed that the mRNA amount of CD31, vWF and VE-cad of
that of the normal group after 1 week (a) and 2 weeks (b) (p < 0.05).
g h i
Figure 5 Immunostaining of CD31 and vWF. The MSCs was induced into endothelial cells which were also transfected with/without SCD1 gene or
empty-vector. Immunocytochemical staining was performed using CD31 and vWF antibodies. Positive staining is visualized by red color for vWF
(Figure 5a, b, c) or CD31 (Figure 5d, e, f). a/d was referred to SCD1 overexpressed group, b/e was normal group, c/f was empty-vector group.
Microscopic image showed that SCD1 overexpressed group (g) had more endothelial cells than normal group (h) and empty-vector group (i).
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ated with a protective effect [25,26]. Dietary fats can mod-
ify CHD risk by their effect on plasma LDL and HDL
cholesterol levels [27]. Consumption of SFAs reduces the
anti-inflammatory potential of HDL and impairs arterial
endothelial function. Consumption of a Mediterranean-
type MUFA-diet produces a decrease in plasma levels of
vWF, TFPI and PAI-1 plasma levels in young healthy
males. Given that these substances are of endothelial ori-
gin, it could be suggested that MUFA of the diet has a
beneficial effect on endothelial function [28].
A large panel of inflammatory genes are regulated by
SFAs. A possible role of SFAs in inflammation has been
demonstrated in vitro. When stimulating human cells with
palmitic acid, the gene expression and protein production
of IL-6 increased [29,30]. The exact mechanisms for these
effects are unknown but proposed involved molecules
are nuclear factor (NF)-κB and protein kinase C [30].
SFAs represent potential contributors to the vascularinflammation in subjects with metabolic syndrome [31].
In the liver, SCD1 deficiency sensitizes cells to injury [32].
In human myotubes, overexpression of SCD1 enhances
triglyceride synthesis and prevents inflammatory and
ER-stress responses to palmitate [33]. Overexpression
of SCD1 in BM-MSCs might increase the growth of in-
duced endothelial cells by decreasing the amount of
SFAs and preventing inflammatory and ER-stress
responses.
Study has shown that SCD1 deficiency increases the rate
of β-oxidation in soleus and red gastrocnemius muscles by
activating of the AMP-activated protein kinase (AMPK)
pathway [34,35]. AMPK leads to phosphorylation and
inactivation of acetyl-CoA carboxylase resulting in de-
creased malonyl-CoA content [36]. Malonyl-CoA is both
an intermediate in de novo synthesis of fatty acids and
an allosteric inhibitor of carnitine palmitoyltransferase
1 (CPT1), the enzyme that transfers long-chain acyl-
CoA molecules from the cytosol to the mitochondria
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levels of malonyl-CoA in the liver and skeletal muscles
of SCD1−/− mice would thus derepress CPT1, resulting
in increased fatty acid oxidation and downregulation of
fatty acid synthesis [37]. High expression of SCD1 is
corresponded with low rates of fatty acid oxidation (de-
creased AMPK activity) [38]. Less fat acid oxidation
might reduce inflammatory responses and be beneficial
for the growth of induced endothelial cells.
SCD1 deficiency results in increased the phosphoryl-
ation of the cAMP response element binding protein
(CREBP) and the activation of the peroxisome proliferator
activated receptor γ (PPARγ) coactivator-1a (PGC-1a)
transcription factor through activation of the β3 adrener-
gic receptor pathway [39], resulting in increased activation
of uncoupling protein 1 (UCP1) in BAT of SCD1−/− mice.
Increased UCP1 expression uncouples oxidative respir-
ation from ATP synthesis, thereby increasing the rate of
basal thermogenesis and consequently, whole body energy
expenditure, in SCD1−/− mice [39]. Therefore, high ex-
pression of SCD1 might decrease the energy expenditure
of cells, helping the growth of induced endothelial cells.
It has been demonstrated that SCD1 modulates the
passage of cycling cells through the G1/S boundary and
the entry into the apoptotic program, and SCD1 regu-
lates mitogenesis by modulating the rate of fatty acid
synthesis, by preventing the toxic accumulation of SFA,
and by controlling the supply of MUFA substrates re-
quired for lipid biosynthesis and cell proliferation [40].
Overexpression of SCD1 in BM-MSCs might contribute
to proliferation of induced endothelial cells by modulat-
ing the passage of cycling cells [41].
Conclusion
This study suggested that overexpression of SCD1 in
BM-MSCs could increase the expression of induced endo-
thelial cells in vitro by showing that the mRNA amount of
CD31, vWF and VE-cad of BM-MSCs increased after
overexpression of SCD1 in vitro. However, the mechanism
by which SCD1 increases the expression of induced endo-
thelial cells of BM-MSCs needs further study.
Methods
Vector system
The lentiviral vector system (Tronolab) includes pCDH,
psPAX2, and pMD. pCDH can express green fluorescent
protein (GFP). Both psPAX2 and pMD contain essential
elements for virus packaging.Reverse 5′-GCTGTCACCTTCACCGTTCC-3′
SCD1** Forward 5′-CAGTGTGTTCGTTGCCACTT-3′-
Reverse 5′–GGTAGTTGTGGAAGCCCTCA-3′-
*Primer used to draw SCD1 fragments for pCDH-SCD1 construction from
SCD1 gene.
**Primer used to monitor the expression of SCD1 in BM-MSCs.Vector construction and virus packaging
Using SCD1 gene purchased from OriGene Technologies
(SC108809) as a template, fragments of the SCD1 gene
were amplified (Figure 3a) using primers capped withBamHI and EcoRI recognition sequences (Table 2 SCD1*).
This fragment was then inserted at a unique BamHI site
and EcoRI site in the shuttle vector (pCDH) to construct
the pCDH-SCD1 plasmid. E. coli was transformed with
pCDH-SCD1 and cultured overnight at 37°C. Polymerase
chain reaction (PCR) of the connected product was per-
formed (Figure 3b), and the construct was confirmed by
DNA sequencing. 293 T cells were transfected by pCDH-
SCD1, psPAX2 and pMD. The virus supernatant was col-
lected after 48 h of cultivation. A concentrated solution of
virus was made with ultra centrifugation and purification,
and the titer of virus was determined. BM-MSCs were
then infected by the packaged virus. GFP-positive cells
were selected by flow cytometry.Western blot
Cells were lysed in RIPA buffer, and protein extraction
was carried out on ice. Protein concentration was deter-
mined by BCA assay. Eight μl of total protein lysate were
mixed with SDS loading buffer, and proteins were sepa-
rated by electrophoresis on 12% SDS-PAGE. After that,
proteins were transferred onto PVDF membranes. After
blocking with 5% skim milk in PBS for 2 hours, mem-
branes were washed and incubated sequentially with pri-
mary anti-SCD1 antibody (ab 19862; Abcam, Cambridge,
USA) and anti-mouse secondary antibody-horseradish
conjugate (Abcam). Western blots were developed colori-
metrically (Figure 3c).Overexpression of SCD1
Total RNA was extracted from BM-MSCs using Trizol
(Invitrogen). Prior to real time PCR (RT-PCR), the RNA
was treated with DNase I. The purified RNA was used
for first-strand cDNA synthesis, and reverse transcrip-
tion was performed using M-MLV reverse transcriptase
with oligo-dT primers according to the manufacturer’s
instructions (Promega). The 170-bp fragment of the SCD1
gene was amplified using primers (Table 2 SCD1**), with
β-actin (Table 2) used as an internal control gene.
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We evaluated Scd1 activity by measuring the conversion
of [14C] stearic acid into [14C] oleic acid after overexpres-
sion SCD1. Cells were incubated with 3 μM (0.25 μCi/dish
of [14C] stearic acid) for 6 h at 37°C in 5% CO2 incubator.
Cells were collected and total lipids were extracted
according to Bligh and Dyer method [42]. Lipids were
saponified and esterified. Radiolabelled fatty acid methyl
esters were separated by RP-HPLC and detected on line
by a radioisotope detector (Packard Flow Scintillation
Analyser, PerkinElmer Life Sciences Inc., Wellesley, MA).
The [14C] oleic acid/([14C] oleic and stearic acids) ratio
was determined as Scd activity [43,44].Endothelial cell induction
BM-MSCs were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) containing 10% fetal bovine serum
(FBS) at 37°C in a humidified atmosphere of 5% CO and
95% air, according to the standard procedure. The cell
lines were routinely passaged using an enzymatic solution
consisting of 0.25% (w/v) trypsin for 5 min at 37°C. The
third generation cells, with 1 × 104 cells/well, were trans-
ferred onto a 12-well plate. After 24 h, endothelial cell
induction was performed with induction medium (low
glucose DMEM containing 10% FBS). Fluorescent quan-
titative PCR of CD31, vWF and VE-cad was performed
after 1 week and 2 weeks to test the growth of induced
endothelial cells.Immunostaining
A total of 1×105 cells were incubated at 4°C with a
mouse mono-clonal anti-CD31 antibody (Southern Bio-
technology, AL, USA). After 45 min, the cells were washed
with PBS and stained with an Alexa 488-conjugated goat
anti-mouse anti-body (Invitrogen) for 30 min at 4°C in the
dark. The cells were also rehydrated and incubated for 2 h
with anti-von Willebrand factor (vWF) (DakoCytomation,
clone F8/86). Subsequently, rabbit-anti-mouse immuno-
globulin (DakoCytomation) was added for 45 min. Sec-
tions and cells were photographed using a Sony color
video camera.Fluorescent quantitative PCR
Total RNA extraction was performed according to the
instruction of RNA extraction kit (QIAGEN). RNA re-
verse transcription was performed following the instruc-
tion of M-MLV (Promega). Fluorescent quantitative PCR
was then performed to detect the expression of CD31,
vWF and VE-cad, with β-actin used as an internal con-
trol gene. Primer sequences were as follows (Table 3).
The amount of PCR copies was obtained according to
the standard curve.Statistical analysis
All experiments were repeated six times. All values were
presented as the means ± SD. Statistically significant dif-
ferences between groups were assessed by an unpaired
Student’s t-test. Differences of p <0.05 were considered
to be statistically significant.
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